Nama Insights

Tema Oncology ETF (CANC)

Health · Tema ETFs · NASDAQ

HealthETF
Tema Oncology ETF (CANC) is an exchange-traded fund in the Health category. It has $211.09M in assets, an expense ratio of 0.75% and a 0.05% dividend yield. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.
Assets under management$211.09M
Expense ratio0.75%
CategoryHealth
Dividend yield0.05%
NAV$41.65
Fund familyTema ETFs
ExchangeNASDAQ

Top holdings

The largest positions Tema Oncology ETF reports, by weight.

HoldingNameWeight
RVMD Revolution Medicines Inc Ordinary Shares 6.07%
LLY Eli Lilly and Co 5.20%
COGT Cogent Biosciences Inc 4.74%
RHHBY Roche Holding AG ADR 4.21%
NOVN.SW Novartis AG Registered Shares 3.82%
BMY Bristol-Myers Squibb Co 3.60%
MRK Merck & Co Inc 3.59%
ABBV AbbVie Inc 3.35%
HALO Halozyme Therapeutics Inc 3.21%
ONC BeOne Medicines Ltd ADR 3.21%

Other Health ETFs

Explore live CANC data on Nama Insights →